FREE Case Review (866) 588-0600

Pradaxa Internal Bleeding Lawsuits on the Rise

The number of legal claims brought against Boehringer Ingelheim over Pradaxa continues to rise, with at least a half dozen new complaints filed in the past week alone.

The number of legal claims brought against Boehringer Ingelheim over its controversial new anticoagulant Pradaxa continues to rise, with at least a half dozen new complaints filed in the past week alone. The lawsuits involve allegations that patients being treated with Pradaxa have suffered uncontrollable bleeding events after receiving the medication.

Free Pradaxa Lawsuit Evaluation: If you or a loved one has been injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?

The new Pradaxa lawsuits, which were filed in Illinois, Louisiana and Tennessee, allege that Boehringer failed to adequately warn the public about the drug’s internal bleeding risks, as well as its lack of an antidote to stop bleeding events that may occur when being treated with the medication.

Two of the complaints filed were on behalf of the estates of patients who allegedly bled to death after being given Pradaxa. The first claim was brought by the daughter of Ray Herndon Celsor, who was prescribed Pradaxa in March 2011 and subsequently suffered severe gastrointestinal bleeding which required him to undergo surgery. After a seemingly successful operation, Celsor’s condition quickly deteriorated and he died in May 2011.

The other wrongful death lawsuit filed this week against Boehringer was brought on behalf of the estate of Bonne Fitzgibbons in the U.S. District Court for the Southern District of Illinois. Fitzgibbons was treated with Pradaxa for non-valvular atrial fibrillation in August 2011, and subsequently developed uncontrollable internal bleeding. She died less than two months after initiating treatment with Pradaxa.

Other recent Pradaxa lawsuits involving non-fatal injuries include those brought by:

  • Thelma Hawthorne (Louisiana)
  • Eva Smith (Illinois)
  • Jacqueline Boston (Illinois)
  • Carole Richardson (Illinois)

When it was first introduced, Boehringer promoted Pradaxa as a superior alternative to Coumadin (generic: warfarin) because it is supposedly easier to use and requires less monitoring. And while the drug may indeed require less patient monitoring, it does not have a reversal agent to stop internal bleeding. With Coumadin, a single dose of vitamin K can be used to counteract internal bleeding events.

According to a January 2012 report released by the Institute for Safe Medication Practices (ISMP), more hemorrhaging events linked to Pradaxa were reported to the U.S. Food & Drug Administration (FDA) during the first quarter of 2011 than were reported with any other drug monitored by the group. During that short time period, at least 505 Pradaxa bleeding events were reported, compared to just 176 cases reported in connection with Coumadin, which came in second on the list.

According to recent estimates, at least 500 patients around the country have died due to Pradaxa’s side effects since it was first introduced in October 2010. Safety investigations are currently underway in the United States, Canada, and the European Union.

Do I Have a Pradaxa Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Pradaxa lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Confidential Case Evaluation: Again, if you or a loved one was injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition